Erythromycin (as ethylsuccinate) - Wyniki wyszukiwania

milpharm limited - erythromycin ethylsuccinate - granules for oral suspension - 500mg/5ml - for the prophylaxis and treatment of infections caused by erythromycin sensitive organisms. erythromycin is highly effective in the treatment of a great variety of clinical infections

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

erythromycin capsule delayed release

kaiser foundation hospitals - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

erythromycin capsule, delayed release

arbor pharmaceuticals, inc. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 250 mg - erythromycin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes, streptococcus pneumoniae, or haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved). (see appropriate sulfonamide labeling for prescribing information). lower respiratory tract infections of mild to moderate severity caused by streptococcus pneumoniae or streptococcus pyogenes . listeriosis caused by listeria monocytogenes . pertussis (whooping cough) caused by bordetella pertussis . erythromycin is effective in eliminating the organism from the nasopharynx of infected individuals rendering them noninfectious. some clinical studies suggest that erythromycin may be helpful in the prophylaxis of pertussis in exposed susceptible ind